Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

clinical trial

Details

Instance of: clinical trial
Start time: 1 February 2021
End time: December 2022
Country: United States
Main subject: metabolite, thrombosis, cough
clinical trial phase: phase I clinical trial, phase II clinical trial
maximum age: 70
minimum age: 10
number of participants: 120
research subject recruitment status: recruiting
short name: COVID
study type: interventional study
title: The Trial Uses Medicinal Herbs to Direct T Cells to Engulf the COVID-19 Virus and Protect the Organs Well

Nothing in the MetaHistoryBook collection references this item yet.